Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Disease and Participant-Related Correlates of Genetic Testing Completion for Hereditary Eye Disorders in a Cohort of over 1400 Patients.

Ophthalmology science·2026
Same author

Precision Is Not Enough: When Tools Outpace Translation in Ocular Gene Therapy.

Genes·2026
Same author

Phenotype-integrated reinterpretation of laboratory-reported <i>ABCA4</i> gene sequencing results improves molecular diagnostic rate in Black/non-White patients and those with late-onset Stargardt macular dystrophy.

Ophthalmic genetics·2026
Same author

Streamlining the diagnostic and management pathways of patients with retinitis pigmentosa.

Ophthalmic genetics·2026
Same author

Application of Machine Learning to Discriminate Photoreceptor Cell Species in Xenotransplanted Chimeric Retinas.

Clinical and translational science·2025
Same author

Gene Therapy Strategies for the Treatment of Bestrophinopathies.

International journal of molecular sciences·2025

Related Experiment Video

Updated: Oct 5, 2025

Methodology for Biomimetic Chemical Neuromodulation of Rat Retinas with the Neurotransmitter Glutamate In Vitro
12:56

Methodology for Biomimetic Chemical Neuromodulation of Rat Retinas with the Neurotransmitter Glutamate In Vitro

Published on: December 19, 2017

7.9K

Bioengineering strategies for restoring vision.

Jasmina Cehajic-Kapetanovic1,2, Mandeep S Singh3, Eberhart Zrenner4

  • 1Nuffield Laboratory of Ophthalmology, University of Oxford, Oxford, UK. enquiries@ndcn.ox.ac.uk.

Nature Biomedical Engineering
|February 1, 2022
PubMed
Summary

Gene and cell therapies, along with retinal prostheses, offer promising treatments for photoreceptor loss in retinal degenerative diseases. These innovative approaches aim to restore vision by repairing or replacing damaged retinal tissue.

More Related Videos

Minimally-invasive Technique for Injection into Rat Optic Nerve
07:34

Minimally-invasive Technique for Injection into Rat Optic Nerve

Published on: May 19, 2015

9.8K
Author Spotlight: Advancing Vision Restoration - Stem Cell-Based Therapy for Retinal Diseases
07:46

Author Spotlight: Advancing Vision Restoration - Stem Cell-Based Therapy for Retinal Diseases

Published on: October 6, 2023

1.1K

Related Experiment Videos

Last Updated: Oct 5, 2025

Methodology for Biomimetic Chemical Neuromodulation of Rat Retinas with the Neurotransmitter Glutamate In Vitro
12:56

Methodology for Biomimetic Chemical Neuromodulation of Rat Retinas with the Neurotransmitter Glutamate In Vitro

Published on: December 19, 2017

7.9K
Minimally-invasive Technique for Injection into Rat Optic Nerve
07:34

Minimally-invasive Technique for Injection into Rat Optic Nerve

Published on: May 19, 2015

9.8K
Author Spotlight: Advancing Vision Restoration - Stem Cell-Based Therapy for Retinal Diseases
07:46

Author Spotlight: Advancing Vision Restoration - Stem Cell-Based Therapy for Retinal Diseases

Published on: October 6, 2023

1.1K

Area of Science:

  • Ophthalmology
  • Regenerative Medicine
  • Neuroscience

Background:

  • Late-stage retinal degenerative diseases cause photoreceptor loss, impairing vision.
  • Current treatments focus on restoring light sensitivity and visual perception.

Purpose of the Study:

  • To review promising gene therapies, cell therapies, and retinal prostheses for retinal degenerative diseases.
  • To discuss the benefits, drawbacks, and influencing factors of each treatment strategy.
  • To summarize emerging technologies for vision restoration.

Main Methods:

  • Review of current gene therapy strategies including gene-replacement and gene-editing.
  • Analysis of cell-based therapies such as cell transplantation.
  • Evaluation of retinal prostheses as electronic solutions.
  • Discussion of tissue reconstruction, repair, and replacement approaches.

Main Results:

  • Gene therapies can attenuate disease progression and reverse function loss.
  • Cell therapies aim to restore photoreceptor-supporting tissue.
  • Retinal prostheses offer an alternative by replacing biological function with electronic devices.

Conclusions:

  • Multiple therapeutic avenues exist for retinal degenerative diseases, each with unique advantages and limitations.
  • The choice between tissue repair/reconstruction and electronic replacement depends on disease stage and specific goals.
  • Advancements in gene therapy, cell therapy, and prosthetics hold significant promise for future vision restoration.